Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O15342
UPID:
VA0E1_HUMAN
Alternative names:
V-ATPase 9.2 kDa membrane accessory protein; V-ATPase M9.2 subunit; Vacuolar proton pump subunit e 1
Alternative UPACC:
O15342; B2R557; D3DQM1; Q6IBE8
Background:
V-type proton ATPase subunit e 1, also known as V-ATPase 9.2 kDa membrane accessory protein, plays a crucial role in cellular processes by being a part of the V0 complex of vacuolar(H+)-ATPase. This enzyme is pivotal for acidifying and maintaining the pH of intracellular compartments. Its presence in certain cell types on the plasma membrane aids in acidifying the extracellular environment, showcasing its versatility.
Therapeutic significance:
Understanding the role of V-type proton ATPase subunit e 1 could open doors to potential therapeutic strategies.